Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were dis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Rev Inst Med Trop Sao Paulo
Prif Awduron: Gomes, Lenyta Oliveira, Teixeira, Marina Rodrigues, da Rosa, Júnior André, Feltrin, Alberi Adolfo, Rodrigues, João Paulo V., Vecchi, Mariane D’Avila, Carneiro, Jane Meire M., Noblat, Lúcia de Araújo C. B., Chachá, Silvana Gama F., Martinelli, Ana de Lourdes C., Pereira, Leonardo Regis L., Silveira, Marysabel Pinto T., Blatt, Carine Raquel, Farias, Mareni Rocha
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Instituto de Medicina Tropical 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://ncbi.nlm.nih.gov/pubmed/29972466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946201860029
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg